Newsroom
August 16, 2021
This Cancer Network article is about a recent U.S. and Swiss study that showed that nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose. Investigators say developing alternative strategies for non-responders will be key. Read story
August 16, 2021
Media contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Katrina Burton, 713-792-8034, kburton@mdanderson.org Shelley Kofler, 512-294-5224, shelley.kofler@uhs-sa.com SAN ANTONIO and HOUSTON (Aug. 16, 2021) – Making a difference by being different. USA Paralympics sitting volleyball player Jillian Williams strives to live by that principle every day, and it’s a motto she will carry with her in Tokyo at […]
August 2, 2021
Dr. Kate Lathrop, Hematology/Mays Cancer Center, was interviewed for this Fox 29 story about the pandemic’s impact on women’s health. Watch story
July 6, 2021
This U.S. News & World Report article features a new study that shows 94% of patients with cancer respond well to COVID-19 vaccines. Study co-authors are from the Mays Cancer Center and the University of Geneva. Read story.
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of the Sacramento Bee addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of The Olympian addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story